544339
Laxmi Dental Ltd
BSELast Traded Price
₹196.25
-0.05 (-0.03%)
Open
₹196.00
High
₹196.30
Low
₹193.85
Prev Close
₹196.30
Industry
Healthcare
Market Cap
1,079.95 Cr
Filing History
Recent corporate announcements and filings for 544339
Business Update
Neutral
2026-10-10 11:04
Concall Schedule
Concall Date: 15th October 2026
Concall Time: 10:00 AM onwards
Governance
Neutral
2026-10-08 18:43
- Laxmi Dental Ltd disclosed board comments regarding fines levied by NSE and BSE for delayed compliance with Regulation 29 (prior intimation of board meeting).
- The board noted the delay was due to procedural oversight with timeline computations over a weekend, and confirmed that the fine of ₹11,800 (inclusive of GST) has been paid.
- The board also approved becoming a member of Leelaben Foundation, a proposed Section 8 company for dental care and social welfare.
Governance
Neutral
2026-10-08 18:34
- Laxmi Dental Ltd approved becoming a member of Leelaben Foundation, a proposed Section 8 Company for establishing rural dental facilities, subsidized treatment, and CSR initiatives, contributing up to ₹1,000 upon winding up.
- The Board reviewed notices from BSE and NSE regarding a delayed compliance penalty of ₹11,800 under Regulation 29(2)/29(3) for August 2026.
- The delay was attributed to an inadvertent procedural oversight due to intervening weekends, and the fine has been paid within the prescribed timeline.
Governance
Neutral
2026-09-29 19:50
- Laxmi Dental Limited held its 22nd Annual General Meeting (AGM) on September 25, 2026.
- All four resolutions, including the adoption of standalone and consolidated financial statements, re-appointment of Mr. Rajesh Vrajlal Khakhar as Whole-Time Director, and approval for variation/extension of IPO proceeds utilization, were passed with the requisite majority.
Governance
Neutral
2026-09-25 14:03
- Laxmi Dental Limited held its 22nd Annual General Meeting (AGM) on September 25, 2026, via Video Conferencing.
- The meeting transacted ordinary and special business items, including the adoption of audited standalone and consolidated financial statements for FY 2025-26.
- Shareholders considered the re-appointment of Mr. Rajesh Vrajlal Khakhar as a Director and approved the variation in utilization and timeline of IPO proceeds.
Routine
Neutral
2026-09-25 13:15
- Trading window closed for all Designated Persons and immediate relatives from October 01, 2026.
- Closure remains until 48 hours after the declaration of Q2/H1 FY27 financial results.
- Board meeting date for approving results to be informed in due course.
Business Update
Neutral
2026-09-23 18:48
- Concall Schedule: Non-Deal Roadshow with analysts/institutional investors
- Concall Date: 29th September 2026
- Concall Time: 9:00 AM onwards
Business Update
Neutral
2026-09-23 18:44
- Concall Schedule
- Concall Date: 28th September 2026
- Concall Time: 9:00 AM onwards
- Organized by: Motilal Oswal Financial Services
- Location: Mumbai
Governance
Positive
2026-09-18 12:03
- Laxmi Dental Limited received approval from NSE and BSE for the listing and trading of 7,911 Equity Shares of face value ₹2/- each.
- These shares were issued under the Laxmi Dental Employee Stock Option Scheme 2024.
- Trading will be effective from September 18, 2026.
Business Update
Neutral
2026-09-04 18:48
- Investor Meeting Schedule
- Meeting Date: September 9, 2026
- Meeting Time: 10:00 AM onwards
- Meeting Type: Group Meeting with Investors/Analysts
- Location: Mumbai Metropolitan Region
Ownership
Positive
2026-08-31 20:33
- Laxmi Dental Limited received approvals from NSE and BSE for listing 59,360 equity shares (face value ₹2 each).
- These shares were issued under the Employee Stock Option Scheme 2024.
- Trading of these shares will commence from September 1, 2026.
Routine
Neutral
2026-08-27 17:20
New Filing detected. See link for details.
Routine
Neutral
2026-08-27 17:14
New Filing detected. See link for details.
Routine
Neutral
2026-08-27 17:09
New Filing detected. See link for details.
Business Update
Positive
2026-08-19 14:12
- Q1 FY27 Consolidated Revenue ₹74.7 Cr vs ₹65.6 Cr (▲13.9% YoY)
- EBITDA ₹14.4 Cr vs ~₹11.94 Cr (▲20.6% YoY)
- PAT ₹10.3 Cr vs ~₹8.32 Cr (▲23.8% YoY)
- EBITDA Margin 19.2% vs ~18% (▲120bps YoY)
- Achieved strong segmental growth in Dental lab business (▲23.5% YoY), International business (▲37.4% YoY), Aligner solutions (▲28.6% YoY), and Paediatric dental business (▲54.4% YoY).
- Executed Letter of Intent to acquire land in Palghar, Maharashtra, for a new owned facility to enhance operational efficiency and scalability.
- Appointed a new CEO for the USA business to strengthen leadership and market-focused strategy.
- Maintains FY27 guidance of 15-20% revenue growth and 18-20% EBITDA margin, with a long-term goal to grow beyond the industry CAGR.
- Plans to deploy 800-1,000 scanners in the current financial year and continue investments in AI-led automation initiatives and branding efforts.
Business Update
Neutral
2026-08-12 15:13
- Audio recording of Laxmi Dental Limited's Q1FY27 Earnings Conference Call is now available for access.
- The call was held on Wednesday, August 12, 2026, at 11:00 A.M. (IST).
- The recording has been uploaded to the company's website.
Financials
Positive
2026-08-11 19:03
- Q1 FY27 Consolidated Revenue ₹747.0 Mn vs ₹656.0 Mn (▲13.9% YoY)
- EBITDA ₹143.6 Mn vs ₹119.1 Mn (▲20.6% YoY)
- PAT ₹103.2 Mn vs ₹83.3 Mn (▲23.8% YoY)
- EBITDA Margin 19.2% vs 18.2% (▲100bps)
Financials
Positive
2026-08-11 19:03
- Q1 FY27 Consolidated Revenue ₹747.0Mn vs ₹656.0Mn (▲13.9% YoY)
- EBITDA ₹143.6Mn vs ₹119.1Mn (▲20.6% YoY)
- PAT ₹103.2Mn vs ₹83.3Mn (▲23.8% YoY)
- EBITDA Margin 19.2% vs 18.2% (▲100bps)
Financials
Positive
2026-08-11 18:56
- Q1 FY27 Consolidated Revenue ₹72.99 Cr vs ₹64.32 Cr (▲13.48% YoY)
- EBITDA ₹16.66 Cr vs ₹13.63 Cr (▲22.24% YoY)
- PAT ₹9.55 Cr vs ₹7.31 Cr (▲30.64% YoY)
- EBITDA Margin 22.83% vs 21.19% (▲164bps)
- Approved the acquisition of land at Palghar, Maharashtra, for ₹62.10 Crores for business expansion by constructing a factory.
- Approved the allotment of 59,360 equity shares to eligible employees under the Laxmi Dental Stock Option Scheme 2024.
Financials
Positive
2026-08-11 18:49
- Q1 FY27 Consolidated Revenue ₹7.47Cr vs ₹6.56Cr (▲13.87% YoY)
- EBITDA ₹1.44Cr vs ₹1.19Cr (▲20.62% YoY)
- PAT ₹1.03Cr vs ₹0.83Cr (▲23.83% YoY)
- EBITDA Margin 19.23% vs 18.15% (▲108 bps)
- Board noted the execution of a Letter of Intent for the acquisition of land at Palghar for ₹6.21Cr to expand business operations by constructing a factory.
- Approved the allotment of 59,360 Equity Shares to eligible employees under the ESOP 2024 scheme.
Financials
Positive
2026-08-11 18:41
- Q1 FY26 Consolidated Operating Revenue ₹74.70Cr vs ₹65.60Cr (▲13.87% YoY)
- EBITDA ₹14.36Cr vs ₹11.91Cr (▲20.62% YoY)
- PAT ₹9.55Cr vs ₹7.31Cr (▲30.64% YoY)
- EBITDA Margin 19.23% vs 18.15% (▲108bps)
- Board noted the execution of a Letter of Intent for land acquisition at Palghar for ₹62.10 Cr, intended for factory expansion.
- Approved the allotment of 59,360 equity shares to employees under the ESOP 2024 scheme.
Financials
Positive
2026-08-11 18:31
- Q1 FY27 Consolidated Operating Revenue ₹74.70Cr vs ₹65.60Cr (▲13.87% YoY)
- EBITDA ₹16.66Cr vs ₹13.63Cr (▲22.24% YoY)
- PAT ₹10.30Cr vs ₹8.39Cr (▲22.76% YoY)
- EBITDA Margin 22.30% vs 20.78% (▲152bps)
- Approved acquisition of land at Palghar, Maharashtra for ₹62.10 Cr for factory expansion.
- Approved allotment of 59,360 equity shares under ESOP 2024, increasing paid-up capital.
- Noted surrender of 1,636 Employee Stock Options by an employee.
Business Update
Neutral
2026-08-07 13:26
- Concall Schedule
- Concall Date: August 12, 2026
- Concall Time: 11:00 AM IST
Governance
Neutral
2026-08-07 13:11
- Board meeting on August 11, 2026, to approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
- Trading window remains closed until 48 hours after results declaration.
Business Update
Neutral
2026-07-10 15:29
- Laxmi Dental Limited disbursed an unsecured loan of ₹25 Lakhs to its subsidiary, Signature Smiles Dental Clinic Private Limited.
- The total outstanding loan amount to the subsidiary is ₹1.25 Crore as of the disclosure date.
- This disbursement is in accordance with a loan agreement to grant an aggregate amount not exceeding ₹50 Lakhs in multiple tranches.
Business Update
Neutral
2026-06-30 15:22
- Concall Schedule
- Concall Date: July 03, 2026
- Concall Time: 11:30 AM
Routine
Neutral
2026-06-26 16:47
- Trading window for Laxmi Dental Limited will remain closed for all Designated Persons and their immediate relatives from July 01, 2026.
- This closure is ahead of the declaration of un-audited financial results for the quarter ended June 30, 2026, and will reopen 48 hours after results declaration.
Business Update
Neutral
2026-06-18 19:21
- Concall Schedule
- Concall Date: June 23, 2026
- Concall Time: 4.15 PM
Business Update
Positive
2026-05-30 15:13
Management expressed confidence in continued strong performance, guiding for sustained revenue growth similar to FY'26's 16.2% over the next two to three years. They anticipate maintaining or improving EBITDA margins to 18-20% and PAT margins to 13-15% by FY27/28, driven by operational leverage, automation, and digital dentistry investments. The company remains debt-free and holds ₹99 Cr in cash and bank balances, with plans for strategic Capex deployment. Key growth drivers include enhanced digital penetration, international market expansion, and new offerings like the iScope 360 remote dental platform.
Routine
Negative
2026-05-30 12:33
CRITICAL RED FLAG DETECTED
Laxmi Dental Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report noted compliance deviations including a 2-day delay in submitting integrated financial filings for the quarter ended March 31, 2025 (fine of INR 11,800 paid), a 37-day delay for the quarter ended September 30, 2025 (fine of INR 218,300 paid). Additionally, there was a one-day delay in disclosing the resignation of the Company Secretary (KMP) due to non-availability of signatory. Related party transactions without prior Audit Committee approval were subsequently ratified.